Navigation Links
Lupin Gets Tentative Nod from FDA for Antidepressant Drug

Leading pharmaceutical company Lupin Ltd has received tentative approval from the US Food and Drug Administration (FDA) for its generic drug Sertraline Hydrochloride for// treatment of major depressive disorder.

Mumbai based Lupin's Sertraline Hydrochloride tablets will be the AB-rated generic equivalent of Pfizer's Zoloft tablets of 25mg, 50mg and 100mg dosage.

"The company intends to launch the generic (drug) on final approval, which is expected upon expiration of the marketing exclusivity (of Pfizer's Zoloft) for the product in February 2007," a company statement said here Tuesday.

This is Lupin's 18th Abbreviated New Drug Application (ANDA) to have received US FDA approval till date.

The company is a leading global player in anti-tuberculosis, cephalosporins (anti-infectives) and cardiovascular drugs (prils and statins) and has a notable presence in the areas of diabetology, non-steroidal anti-inflammatory drugs (NSAIDS) and asthma.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Lupin flour may cause peanut allergy like reactions
2. Lupin Gets USFDA Approval For Quinapril Tablets
3. US Court Rules Against Lupin in Ramipril Patent Case
4. Lupin Gets USFDA Approval for Meloxicam
5. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
6. Tentative inhaled steroids is worse for lung patients
7. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
8. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Antidepressant helps obesity
11. Antidepressants increase gastric bleeding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... ... the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, ... How will the new EU MDR language change the way manufacturers approach ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare ... Assurance, at HCCA’s 21st annual Compliance Institute on March 26-28 in National Harbor, ... for all medical chart types with a comprehensive set of features including built-in ...
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... ... ... Journey Through Heaven”: the true-life account of a man who faced death and emerged ... for His people. “My Journey Through Heaven” is the creation of published author Earl ... grandchildren living and doing for God as best they can. , Published by Christian ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... existence of God. “A Respectful Response To Atheist Manifesto” is the creation of ... to his wife, Nancy, for sixty years. He holds graduate degrees from Kent ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... company focused on the development of a once-daily, ... or NASH, and other liver diseases, today reported ... ended December 31, 2016, and announced new and exciting ... potential direct effect on liver fibrosis. The data ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
(Date:3/22/2017)... 23, 2017 ReportsnReports.com adds Global ... research report. The global vagus nerve stimulation market analyst ... focus toward minimally invasive VNS procedures. Few years ago, ... developed countries having high standards of healthcare infrastructure. ... ...
Breaking Medicine Technology: